Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Anke Gerhardt"'
Autor:
Jan Dürig, Jens Uhlig, Anke Gerhardt, Markus Ritter, Gunnar Hapke, Jörg Heßling, Peter Staib, Frieder Wolff, Katja Krumm, Ludwig Fischer vonWeikersthal
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 2739-2751 (2023)
Abstract Background Rituximab has become a standard treatment for non‐Hodgkin lymphoma. Clinical studies have demonstrated the efficacy of rituximab in combination with standard chemotherapies in the treatment of follicular lymphoma (FL) and diffus
Externí odkaz:
https://doaj.org/article/39f98f0edd424b1abc4ef74d4c24f12b
Autor:
Jan Dürig, Jens Uhlig, Anke Gerhardt, Markus Ritter, Gunnar Hapke, Jörg Heßling, Peter Staib, Frieder Wolff, Katja Krumm, Ludwig Fischer von Weikersthal
Publikováno v:
Cancer Medicine. 12:2739-2751
OA Förderung 2022 Background Rituximab has become a standard treatment for non-Hodgkin lymphoma. Clinical studies have demonstrated the efficacy of rituximab in combination with standard chemotherapies in the treatment of follicular lymphoma (FL) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cfdf83143e9dbc4a7795d2eb6f353c9
https://doi.org/10.1002/cam4.5160
https://doi.org/10.1002/cam4.5160
Autor:
Manfred Welslau, Sjaak Bloem, Rudolf Schlag, Steffen Dörfel, Sabrina Buchholz, Lukas Vornholz, Holger Schulz, Anke Gerhardt
Publikováno v:
Blood. 140:12400-12402
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7482f38ac115c7caa6d13c2826db0e1
https://doi.org/10.1182/blood-2022-156504
https://doi.org/10.1182/blood-2022-156504
Autor:
Jolanta Dengler, Hans Tesch, Kathleen Jentsch-Ullrich, Anke Gerhardt, Clemens Schulte, Jörg Lipke, Gunnar Löwe, Alexander Kiani
Publikováno v:
Acta Haematologica. 145:603-610
Introduction: Treatment-free remission (TFR) is increasingly considered as treatment goal for patients with chronic myeloid leukemia (CML), but information on the disposition and outcome of TFR in clinical practice is scarce. Here, we report the char
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0b2eb1ddac6b8c39b9e33701fb173ef
https://doi.org/10.1159/000525935
https://doi.org/10.1159/000525935
Autor:
Tamara Seidl, Falk Thielemann, Anke Gerhardt, Hartmut Gaulrapp, Angelika Zierl, Silke Buchholz, Antje Naumann, Bettina Winter, Klaus Rodens
Publikováno v:
Zeitschrift für Orthopädie und Unfallchirurgie.
ZusammenfassungHüftreifungsstörungen stellen in Mitteleuropa die häufigste muskuloskelettale Erkrankung im Neugeborenalter dar. Der Begriff Hüftreifungsstörung umfasst dabei sowohl dysplastische als auch luxierte Gelenke. Bei einem dysplastische
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bc6748b7883d4ab825b0f8145b2d765
https://doi.org/10.1055/a-1838-5525
https://doi.org/10.1055/a-1838-5525
Autor:
Tamara, Seidl, Falk, Thielemann, Anke, Gerhardt, Hartmut, Gaulrapp, Angelika, Zierl, Silke, Buchholz, Antje, Naumann, Bettina, Winter, Klaus, Rodens
Publikováno v:
Zeitschrift fur Orthopadie und Unfallchirurgie.
Hip developmental disorders are the most common musculoskeletal disease in newborns in Central Europe. The definition of hip developmental disorder includes both dysplastic and dislocated joints. In a dysplastic joint, shearing forces induce a growin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dffe50c6b38575834e3de19ac03e0263
https://pubmed.ncbi.nlm.nih.gov/35882353
https://pubmed.ncbi.nlm.nih.gov/35882353
Autor:
Meinolf Karthaus, Nikolaus Ansorge, Gleb Barmashenko, Christof Burkart, Thomas Decker, Thomas Jens Ettrich, Anke Gerhardt, Sabine Hoefling, Lutz Jacobasch, Michael Koenigsmann, Sebastian Räth, Markos Schulte, Nadine Schulte, Andreas Schwarzer, Gabriele Margareta Siegler, Dirk Waldschmidt, Manfred P. Lutz
Publikováno v:
Journal of Clinical Oncology. 41:721-721
721 Background: Second-line Nal-Iri/5-Fluorouracil/Folinic Acid (Nal-Iri/5-FU/LV) increases overall survival of unselected patients (pts) with metastatic pancreatic ductal adenocarcinoma (PDAC) after gemcitabine-based therapy. It is unknown, which pt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e857ee5f362e87cbd09e0f1fe8df4a9
https://doi.org/10.1200/jco.2023.41.4_suppl.721
https://doi.org/10.1200/jco.2023.41.4_suppl.721
Autor:
Anke Gerhardt
Publikováno v:
KZfSS Kölner Zeitschrift für Soziologie und Sozialpsychologie. 53:797-799
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e3b5176b73074f47347111f51a57c00
https://doi.org/10.1007/s11577-001-0124-0
https://doi.org/10.1007/s11577-001-0124-0